In collaboration with WHO, IBPC/NIFDC participated in the drafting group to develop the WHO Recommendations to assure the quality, safety and efficacy of Enterovirus 71 vaccines (activated). The recommendation has been adopted by the Seventy-second meeting of the World Health Organization Expert Committee on Biological Standardization, 19–23 October 2020.